Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2018 |
| Reihe/Periodikum: | Health Economics Review ; volume 8, issue 1 ; ISSN 2191-1991 |
| Verlag/Hrsg.: |
Springer Science and Business Media LLC
|
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-29638177 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | http://dx.doi.org/10.1186/s13561-018-0197-3 |
